Efficacy and Safety of Rituximab in Biologic-Naive Patients with Rheumatoid Arthritis vs Anti-Tnf Therapy Failure

OBJECTIVES: Our aim was to compare an AntiCD20 therapy (rituximab) for rheumatoid arthritis in two patient populations (Group 1), anti-TNFα naïve patients and inadequate responders to Anti-TNFα therapy (Group 2). METHODS: We analyzed the efficacy of the drug Rituximab (RTX) in RA patients who failed...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutierrez-Gonzalez, Luis Arturo, Gudiño, Marco Antonio Rivera, Ceija, Ibell Oropeza, Leonet, Marialina Marin, Noguera, Zair Tovar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812784/
https://www.ncbi.nlm.nih.gov/pubmed/24179556
http://dx.doi.org/10.2174/1874312920130913004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812784/
https://www.ncbi.nlm.nih.gov/pubmed/24179556
http://dx.doi.org/10.2174/1874312920130913004

Ejemplares similares